Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CD49d antagonists(Integrin alpha-4 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC93H104N18O24S6 |
InChIKeyLVISQNUEBNOMII-UHFFFAOYSA-N |
CAS Registry873687-18-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple sclerosis relapse | Phase 1 | US | 01 Mar 2010 | |
Multiple sclerosis relapse | Phase 1 | CA | 01 Mar 2010 | |
Hematologic Neoplasms | Phase 1 | US | - | |
Hematologic Neoplasms | Phase 1 | - | - |